Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Novartis has no plans to bid for U.S.-based generic drugmaker Actavis, which is the subject of intense takeover speculation, a spokesman for the Swiss drugmaker said on Thursday. “We have no intention to pursue them,” spokesman Eric Althoff said in response to inquiries.
Help employers find you! Check out all the jobs and post your resume.
